Monoclonal antibodies against CD30 lacking fucosyl residues

Details for Australian Patent Application No. 2006214033 (hide)

Owner Medarex, Inc.

Inventors Black, Amelia Nancy; Cardarelli, Josephine M.

Agent Shelston IP

Pub. Number AU-B-2006214033

PCT Pub. Number WO2006/089232

Priority 60/654,197 18.02.05 US

Filing date 17 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 11 August 2011

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089232 Priority application(s): WO2006/089232

11 August 2011 Application Accepted

  Published as AU-B-2006214033

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214034-Methods and systems for diagnosis, prognosis and selection of treatment of leukemia

2006214032-Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues